Baseline demographics of patients from the PALADIN study
| Parameters | PALADIN (n=95 patients, 115 eyes) |
| Mean age, years | 67.22 |
| Male, n (%) | 46 (48.4) |
| Duration of DMO, years | |
| Mean±SE | 4.73±0.267 |
| Range, minimum–maximum | 1.0–13.0 |
| Lens status, n (%) | |
| Pseudophakic | 103 (89.6) |
| Phakic | 12 (10.4) |
| Baseline IOP, mm Hg | |
| Mean±SE | 14.92±0.347 |
| Range, minimum–maximum | 7.0–25.7 |
| Baseline BCVA, mean±SD, ETDRS letters | 61.3±16.4 |
| Baseline CST, mean±SD, µm | 383.1±133.36 |
| Baseline CST ≤300 µm, n (%) | 38 (33.6) |
| Baseline BCVA ≥20/40, n (%) | 39 (33.9) |
BCVA, best-corrected visual acuity; CST, central subfield thickness; DMO, diabetic macular oedema; ETDRS, Early Treatment Diabetic Retinopathy Study; IOP, intraocular pressure.